Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A Critically Appraised Topic.
Joerg AlbrechtP A BaineB LadizinskiGregor Borut Ernst JemecM BigbyPublished in: The British journal of dermatology (2018)
The analysed risks associated with a combination of clindamycin and rifampicin for hidradenitis suppurative cluster within the first 10 weeks. Treatment can be continued beyond 10 weeks, if clinically necessary.